11 – 20 of 22
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
-
Mark
SOX5/6/21 prevent oncogene-driven transformation of brain stem cells
Kurtsdotter, Idha ; Topcic, Danijal ; Karlén, Alexandra ; Singla, Bhumica ; Hagey, Daniel W. ; Bergsland, Maria ; Siesjö, Peter LU
; Nistér, Monica
; Carlson, Joseph W.
and Lefebvre, Veronique
, et al.
(2017)
In Cancer Research
77(18).
p.4985-4997
- Contribution to journal › Article
- 2016
-
Mark
Preoperative systemic levels of VEGFA, IL-7, IL-17A, and TNF-β delineate two distinct groups of children with brain tumors
Sandén, Emma LU ; Enríquez Pérez, Julio LU
; Visse, Edward
LU
; Kool, Marcel
; Carén, Helena
; Siesjö, Peter
LU
and Darabi, Anna
LU
(2016)
In Pediatric Blood & Cancer
63(12).
p.2112-2122
- Contribution to journal › Article
- 2015
-
Mark
Aberrant immunostaining pattern of the CD24 glycoprotein in clinical samples and experimental models of pediatric medulloblastomas.
Sandén, Emma LU ; Dyberg, Cecilia ; Krona, Cecilia ; Visse, Edward LU ; Carén, Helena ; Northcott, Paul A ; Kool, Marcel ; Ståhl, Nils LU ; Persson, Annette LU and Englund, Elisabet LU
, et al.
(2015)
In Journal of Neuro-Oncology
123(1).
p.1-13
- Contribution to journal › Article
- 2014
-
Mark
Intratumoral COX-2 inhibition enhances GM-CSF immunotherapy against established mouse GL261 brain tumors.
Eberstål, Sofia LU ; Sandén, Emma LU ; Fritzell, Sara LU ; Darabi, Anna LU ; Visse, Edward LU and Siesjö, Peter LU
(2014)
In International Journal of Cancer
134(11).
p.2748-2753
- Contribution to journal › Article
- 2013
-
Mark
Intratumoral temozolomide synergizes with immunotherapy in a T cell-dependent fashion.
Fritzell, Sara LU ; Sandén, Emma LU ; Eberstål, Sofia LU ; Visse, Edward LU ; Darabi, Anna LU and Siesjö, Peter LU
(2013)
In Cancer Immunology and Immunotherapy
62(9).
p.1463-1474
- Contribution to journal › Article
- 2012
-
Mark
Inhibition of cyclooxygenase-2 enhances immunotherapy against experimental brain tumors.
Eberstål, Sofia LU ; Badn, Wiaam LU ; Fritzell, Sara LU ; Esbjörnsson, Magnus ; Darabi, Anna LU ; Visse, Edward LU and Siesjö, Peter LU
(2012)
In Cancer immunology, immunotherapy
61(8).
p.1191-1199
- Contribution to journal › Article
-
Mark
ANALYSIS OF CLUSTER OF DIFFERENTIATION (CD) MARKERS IN PEDIATRIC BRAIN TUMORS CAN BE USED AS A DIAGNOSTIC AND PROGNOSTIC TOOL
Sandén, Emma LU ; Visse, Edward LU ; Siesjö, Peter LU
and Darabi, Anna
LU
(2012)
15th International Symposium on Pediatric Neuro-Oncology
In Neuro-Oncology
14(suppl. 1).
p.43-48
- Contribution to journal › Published meeting abstract
- 2009
-
Mark
Cure of established GL261 mouse gliomas after combined immunotherapy with GM-CSF and IFNgamma is mediated by both CD8(+) and CD4(+) T-cells.
Enell Smith, Karin LU ; Fritzell, Sara LU ; Badn, Wiaam LU ; Eberstål, Sofia LU ; Janelidze, Shorena LU ; Visse, Edward LU ; Darabi, Anna LU and Siesjö, Peter LU
(2009)
In International Journal of Cancer
124(3).
p.630-637
- Contribution to journal › Article
-
Mark
CD133+ and nestin+ tumor-initiating cells dominate in N29 and N32 experimental gliomas.
Bexell, Daniel LU ; Gunnarsson, Salina LU ; Siesjö, Peter LU
; Bengzon, Johan
LU
and Darabi, Anna
LU
(2009)
In International Journal of Cancer
125(1).
p.15-22
- Contribution to journal › Article
- 2007
-
Mark
Synergism between GM-CSF and IFNgamma: Enhanced immunotherapy in mice with glioma.
Smith, Karin E ; Janelidze, Shorena LU ; Visse, Edward LU ; Badn, Wiaam LU ; Salford, Leif LU ; Siesjö, Peter LU
and Darabi, Anna
LU
(2007)
In International Journal of Cancer
120(1).
p.75-80
- Contribution to journal › Article